Natalie Nokoff
Concepts (274)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transgender Persons | 14 | 2025 | 201 | 5.300 |
Why?
| | Adrenal Hyperplasia, Congenital | 12 | 2025 | 39 | 4.350 |
Why?
| | Disorders of Sex Development | 12 | 2025 | 39 | 3.010 |
Why?
| | Testosterone | 12 | 2026 | 404 | 2.450 |
Why?
| | Athletic Performance | 3 | 2025 | 81 | 1.730 |
Why?
| | Gender Dysphoria | 5 | 2024 | 19 | 1.290 |
Why?
| | Estradiol | 6 | 2026 | 523 | 1.240 |
Why?
| | Gonadotropin-Releasing Hormone | 3 | 2024 | 213 | 1.140 |
Why?
| | Mental Disorders | 5 | 2025 | 1124 | 1.100 |
Why?
| | Neurodevelopmental Disorders | 4 | 2025 | 210 | 1.060 |
Why?
| | Insulin Resistance | 4 | 2026 | 1218 | 1.020 |
Why?
| | Cardiovascular Diseases | 4 | 2025 | 2089 | 1.010 |
Why?
| | Sex Determination Analysis | 1 | 2025 | 6 | 0.920 |
Why?
| | Androgen Antagonists | 1 | 2025 | 92 | 0.850 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 69 | 0.840 |
Why?
| | Genitalia | 6 | 2021 | 34 | 0.800 |
Why?
| | Puberty | 3 | 2024 | 152 | 0.790 |
Why?
| | Turner Syndrome | 5 | 2025 | 65 | 0.780 |
Why?
| | Sports | 1 | 2025 | 219 | 0.750 |
Why?
| | Glomerular Filtration Rate | 2 | 2025 | 753 | 0.730 |
Why?
| | Adrenal Insufficiency | 2 | 2021 | 29 | 0.690 |
Why?
| | Genital Diseases, Female | 2 | 2021 | 31 | 0.680 |
Why?
| | Male | 49 | 2026 | 70063 | 0.660 |
Why?
| | Female | 56 | 2026 | 75729 | 0.650 |
Why?
| | Adolescent | 27 | 2025 | 22064 | 0.650 |
Why?
| | Mood Disorders | 1 | 2021 | 139 | 0.650 |
Why?
| | Kidney | 3 | 2025 | 1482 | 0.650 |
Why?
| | Caregivers | 5 | 2022 | 940 | 0.620 |
Why?
| | Gonadal Steroid Hormones | 2 | 2023 | 138 | 0.610 |
Why?
| | Body Composition | 2 | 2020 | 703 | 0.600 |
Why?
| | Urogenital Surgical Procedures | 3 | 2020 | 5 | 0.590 |
Why?
| | Child | 30 | 2025 | 22342 | 0.580 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 623 | 0.570 |
Why?
| | Parents | 8 | 2022 | 1440 | 0.560 |
Why?
| | Emergency Service, Hospital | 2 | 2024 | 2197 | 0.560 |
Why?
| | Anxiety | 4 | 2023 | 1078 | 0.560 |
Why?
| | Humans | 64 | 2026 | 141267 | 0.520 |
Why?
| | Genital Diseases, Male | 1 | 2016 | 17 | 0.510 |
Why?
| | Hypertension | 2 | 2022 | 1253 | 0.510 |
Why?
| | Biomarkers | 4 | 2025 | 4179 | 0.480 |
Why?
| | Case-Control Studies | 5 | 2025 | 3580 | 0.460 |
Why?
| | Child, Preschool | 15 | 2025 | 11473 | 0.450 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 876 | 0.400 |
Why?
| | Emergencies | 1 | 2014 | 180 | 0.390 |
Why?
| | Klinefelter Syndrome | 2 | 2025 | 70 | 0.380 |
Why?
| | Electronic Health Records | 4 | 2025 | 1131 | 0.370 |
Why?
| | Ambulatory Care Facilities | 1 | 2014 | 247 | 0.360 |
Why?
| | Body Mass Index | 1 | 2020 | 2377 | 0.350 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5653 | 0.340 |
Why?
| | Acute Disease | 1 | 2014 | 1012 | 0.340 |
Why?
| | Obesity | 3 | 2022 | 3001 | 0.340 |
Why?
| | Sexual Development | 6 | 2023 | 17 | 0.330 |
Why?
| | Athletes | 2 | 2025 | 413 | 0.320 |
Why?
| | Glucocorticoids | 2 | 2025 | 533 | 0.320 |
Why?
| | Autism Spectrum Disorder | 3 | 2025 | 418 | 0.310 |
Why?
| | Infant | 11 | 2025 | 9801 | 0.310 |
Why?
| | Propensity Score | 2 | 2021 | 335 | 0.310 |
Why?
| | Sex Characteristics | 4 | 2023 | 786 | 0.300 |
Why?
| | Odds Ratio | 2 | 2021 | 1057 | 0.290 |
Why?
| | Insulin | 1 | 2019 | 2460 | 0.290 |
Why?
| | Androstenedione | 2 | 2024 | 11 | 0.270 |
Why?
| | Amines | 2 | 2024 | 40 | 0.260 |
Why?
| | Thiazoles | 2 | 2024 | 136 | 0.260 |
Why?
| | Gender Identity | 4 | 2024 | 128 | 0.250 |
Why?
| | Genetic Predisposition to Disease | 3 | 2019 | 2373 | 0.250 |
Why?
| | Testosterone Congeners | 2 | 2023 | 9 | 0.250 |
Why?
| | Logistic Models | 2 | 2021 | 2095 | 0.240 |
Why?
| | Autoimmunity | 1 | 2012 | 906 | 0.240 |
Why?
| | Pediatrics | 1 | 2014 | 1099 | 0.240 |
Why?
| | Medroxyprogesterone Acetate | 1 | 2025 | 37 | 0.230 |
Why?
| | Prospective Studies | 7 | 2026 | 7787 | 0.230 |
Why?
| | Quality of Life | 7 | 2021 | 3021 | 0.230 |
Why?
| | Longitudinal Studies | 5 | 2024 | 2923 | 0.230 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2013 | 3788 | 0.230 |
Why?
| | Mineralocorticoids | 1 | 2025 | 7 | 0.230 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2014 | 1396 | 0.230 |
Why?
| | Sex Chromosome Aberrations | 2 | 2025 | 68 | 0.220 |
Why?
| | Sex Chromosome Disorders | 1 | 2025 | 28 | 0.220 |
Why?
| | Contraceptive Agents, Female | 1 | 2025 | 79 | 0.220 |
Why?
| | Familial Hypophosphatemic Rickets | 1 | 2024 | 6 | 0.210 |
Why?
| | Hypophosphatemia | 1 | 2024 | 17 | 0.210 |
Why?
| | Trisomy | 1 | 2025 | 78 | 0.210 |
Why?
| | Blood Proteins | 1 | 2026 | 250 | 0.210 |
Why?
| | Genitalia, Female | 2 | 2021 | 41 | 0.210 |
Why?
| | Endometriosis | 1 | 2024 | 57 | 0.200 |
Why?
| | Contraception | 1 | 2025 | 165 | 0.200 |
Why?
| | Primary Health Care | 1 | 2014 | 1756 | 0.200 |
Why?
| | Neonatal Screening | 1 | 2025 | 172 | 0.200 |
Why?
| | Risk Factors | 5 | 2021 | 10482 | 0.190 |
Why?
| | Infant, Newborn | 3 | 2025 | 6262 | 0.190 |
Why?
| | Leuprolide | 1 | 2022 | 21 | 0.190 |
Why?
| | Androgens | 1 | 2023 | 187 | 0.180 |
Why?
| | Uncertainty | 2 | 2020 | 137 | 0.180 |
Why?
| | Sports Medicine | 1 | 2023 | 117 | 0.180 |
Why?
| | Young Adult | 7 | 2025 | 13667 | 0.180 |
Why?
| | Wnt4 Protein | 1 | 2021 | 20 | 0.170 |
Why?
| | Proteome | 1 | 2026 | 483 | 0.170 |
Why?
| | Oxygen Consumption | 1 | 2024 | 714 | 0.170 |
Why?
| | Monosomy | 1 | 2021 | 12 | 0.170 |
Why?
| | Cardiology | 1 | 2024 | 280 | 0.170 |
Why?
| | Overweight | 2 | 2022 | 587 | 0.170 |
Why?
| | Adaptation, Psychological | 2 | 2016 | 679 | 0.170 |
Why?
| | Dyslipidemias | 1 | 2022 | 175 | 0.160 |
Why?
| | Child Behavior Disorders | 1 | 2021 | 142 | 0.160 |
Why?
| | Decision Making | 3 | 2022 | 951 | 0.160 |
Why?
| | Adult | 13 | 2026 | 39203 | 0.160 |
Why?
| | Sex Hormone-Binding Globulin | 1 | 2019 | 53 | 0.150 |
Why?
| | Growth Hormone | 1 | 2019 | 99 | 0.150 |
Why?
| | Sexual Maturation | 1 | 2019 | 55 | 0.150 |
Why?
| | Inservice Training | 1 | 2020 | 119 | 0.150 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 100 | 0.150 |
Why?
| | Liver Diseases | 1 | 2022 | 302 | 0.150 |
Why?
| | Stress Disorders, Post-Traumatic | 2 | 2019 | 862 | 0.150 |
Why?
| | Postmenopause | 1 | 2021 | 369 | 0.150 |
Why?
| | Vascular Malformations | 1 | 2019 | 50 | 0.150 |
Why?
| | Women's Health | 1 | 2021 | 308 | 0.150 |
Why?
| | Capillaries | 1 | 2019 | 124 | 0.150 |
Why?
| | Reproductive Health | 1 | 2019 | 91 | 0.140 |
Why?
| | Suicidal Ideation | 1 | 2024 | 539 | 0.140 |
Why?
| | Phosphoproteins | 1 | 2021 | 335 | 0.140 |
Why?
| | Developmental Disabilities | 1 | 2021 | 284 | 0.140 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2021 | 189 | 0.140 |
Why?
| | Polycystic Ovary Syndrome | 1 | 2021 | 179 | 0.140 |
Why?
| | Mentors | 1 | 2020 | 213 | 0.140 |
Why?
| | Mitochondria | 1 | 2024 | 975 | 0.140 |
Why?
| | Erythrocytes | 1 | 2023 | 707 | 0.140 |
Why?
| | Interprofessional Relations | 1 | 2020 | 282 | 0.140 |
Why?
| | Emotional Adjustment | 1 | 2017 | 18 | 0.130 |
Why?
| | Mentoring | 1 | 2020 | 153 | 0.130 |
Why?
| | Parent-Child Relations | 2 | 2019 | 285 | 0.130 |
Why?
| | Anxiety Disorders | 2 | 2023 | 374 | 0.130 |
Why?
| | Diabetic Nephropathies | 1 | 2020 | 293 | 0.130 |
Why?
| | Metformin | 1 | 2021 | 330 | 0.130 |
Why?
| | Urogenital Abnormalities | 1 | 2018 | 71 | 0.130 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 305 | 0.130 |
Why?
| | Linear Models | 1 | 2019 | 855 | 0.130 |
Why?
| | Suicide | 1 | 2024 | 669 | 0.130 |
Why?
| | Sexual and Gender Minorities | 1 | 2021 | 234 | 0.130 |
Why?
| | Analysis of Variance | 1 | 2019 | 1314 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2019 | 529 | 0.120 |
Why?
| | Hemodynamics | 1 | 2021 | 1100 | 0.120 |
Why?
| | Students, Medical | 1 | 2021 | 368 | 0.120 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 880 | 0.120 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 534 | 0.120 |
Why?
| | Perception | 1 | 2018 | 375 | 0.120 |
Why?
| | Databases, Factual | 1 | 2021 | 1446 | 0.120 |
Why?
| | Adipose Tissue | 1 | 2020 | 645 | 0.120 |
Why?
| | Urologic Surgical Procedures | 1 | 2016 | 118 | 0.120 |
Why?
| | Hypopituitarism | 1 | 2015 | 16 | 0.110 |
Why?
| | Hypoglycemia | 1 | 2019 | 467 | 0.110 |
Why?
| | Prognosis | 2 | 2020 | 4077 | 0.110 |
Why?
| | Pilot Projects | 1 | 2020 | 1815 | 0.110 |
Why?
| | Hospitalization | 1 | 2024 | 2272 | 0.110 |
Why?
| | Stress, Psychological | 2 | 2019 | 1122 | 0.100 |
Why?
| | Sex Factors | 1 | 2019 | 2054 | 0.100 |
Why?
| | Prevalence | 3 | 2025 | 2793 | 0.100 |
Why?
| | Follow-Up Studies | 2 | 2020 | 5213 | 0.100 |
Why?
| | Depressive Disorder | 1 | 2015 | 374 | 0.090 |
Why?
| | Age Factors | 1 | 2019 | 3292 | 0.090 |
Why?
| | Surveys and Questionnaires | 4 | 2024 | 5937 | 0.090 |
Why?
| | HLA Antigens | 1 | 2013 | 234 | 0.090 |
Why?
| | Mental Health | 3 | 2025 | 754 | 0.090 |
Why?
| | United States | 6 | 2025 | 15245 | 0.090 |
Why?
| | Middle Aged | 4 | 2026 | 34597 | 0.080 |
Why?
| | Gynecologic Surgical Procedures | 2 | 2022 | 66 | 0.080 |
Why?
| | Blood Glucose | 1 | 2019 | 2275 | 0.080 |
Why?
| | Colorado | 1 | 2019 | 4599 | 0.080 |
Why?
| | Postoperative Complications | 2 | 2018 | 2824 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2731 | 0.070 |
Why?
| | Phenotype | 3 | 2023 | 3177 | 0.070 |
Why?
| | Aged | 2 | 2025 | 24798 | 0.070 |
Why?
| | Emotions | 2 | 2022 | 575 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2524 | 0.060 |
Why?
| | Postoperative Period | 2 | 2017 | 360 | 0.060 |
Why?
| | Cohort Studies | 3 | 2022 | 5802 | 0.060 |
Why?
| | Glucose Clamp Technique | 1 | 2026 | 197 | 0.060 |
Why?
| | Autoantibodies | 1 | 2013 | 1474 | 0.060 |
Why?
| | XYY Karyotype | 1 | 2025 | 23 | 0.060 |
Why?
| | Sex Chromosome Disorders of Sex Development | 1 | 2025 | 17 | 0.060 |
Why?
| | Chromosomes, Human, X | 1 | 2025 | 77 | 0.050 |
Why?
| | Gonadoblastoma | 1 | 2024 | 6 | 0.050 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 1 | 2024 | 28 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2025 | 74 | 0.050 |
Why?
| | Hypercalciuria | 1 | 2024 | 2 | 0.050 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type IIc | 1 | 2024 | 3 | 0.050 |
Why?
| | 17-alpha-Hydroxyprogesterone | 1 | 2023 | 3 | 0.050 |
Why?
| | Vomiting | 1 | 2024 | 129 | 0.050 |
Why?
| | Cystatin C | 1 | 2023 | 65 | 0.050 |
Why?
| | Mutation | 3 | 2021 | 4009 | 0.050 |
Why?
| | Headache | 1 | 2024 | 152 | 0.050 |
Why?
| | Sex Chromosomes | 1 | 2023 | 46 | 0.050 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2023 | 147 | 0.050 |
Why?
| | Phosphates | 1 | 2024 | 179 | 0.050 |
Why?
| | Animals | 3 | 2021 | 37642 | 0.050 |
Why?
| | Aneuploidy | 1 | 2023 | 88 | 0.050 |
Why?
| | Virilism | 1 | 2022 | 7 | 0.050 |
Why?
| | Fever | 1 | 2024 | 310 | 0.050 |
Why?
| | Focus Groups | 1 | 2025 | 567 | 0.050 |
Why?
| | Counseling | 1 | 2025 | 395 | 0.050 |
Why?
| | Hydrocortisone | 1 | 2024 | 309 | 0.050 |
Why?
| | Menstrual Cycle | 1 | 2022 | 134 | 0.040 |
Why?
| | Sex Differentiation | 1 | 2021 | 10 | 0.040 |
Why?
| | Creatinine | 1 | 2023 | 491 | 0.040 |
Why?
| | Hirsutism | 1 | 2021 | 12 | 0.040 |
Why?
| | Karyotype | 1 | 2021 | 17 | 0.040 |
Why?
| | Alopecia | 1 | 2021 | 32 | 0.040 |
Why?
| | Chromosomes, Human, Y | 1 | 2021 | 26 | 0.040 |
Why?
| | Mammary Glands, Human | 1 | 2021 | 66 | 0.040 |
Why?
| | Health Occupations | 1 | 2021 | 34 | 0.040 |
Why?
| | Mosaicism | 1 | 2021 | 74 | 0.040 |
Why?
| | Retrospective Studies | 3 | 2024 | 16373 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 283 | 0.040 |
Why?
| | Polymicrogyria | 1 | 2019 | 6 | 0.040 |
Why?
| | Uterus | 1 | 2021 | 221 | 0.040 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2021 | 310 | 0.040 |
Why?
| | Comorbidity | 1 | 2025 | 1672 | 0.040 |
Why?
| | Laparoscopy | 1 | 2024 | 463 | 0.040 |
Why?
| | Canada | 1 | 2021 | 419 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1980 | 0.040 |
Why?
| | Proteomics | 1 | 2026 | 1137 | 0.040 |
Why?
| | Physicians, Women | 1 | 2020 | 88 | 0.040 |
Why?
| | Peer Group | 1 | 2020 | 247 | 0.040 |
Why?
| | Minority Groups | 1 | 2020 | 278 | 0.030 |
Why?
| | Genitalia, Male | 1 | 2018 | 11 | 0.030 |
Why?
| | Career Choice | 1 | 2020 | 233 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1526 | 0.030 |
Why?
| | Ovarian Neoplasms | 1 | 2024 | 582 | 0.030 |
Why?
| | Esthetics | 1 | 2018 | 47 | 0.030 |
Why?
| | Health Status | 1 | 2023 | 822 | 0.030 |
Why?
| | Universities | 1 | 2020 | 451 | 0.030 |
Why?
| | Surgery, Plastic | 1 | 2018 | 48 | 0.030 |
Why?
| | Social Media | 1 | 2020 | 160 | 0.030 |
Why?
| | Urologic Surgical Procedures, Male | 1 | 2017 | 32 | 0.030 |
Why?
| | Precision Medicine | 1 | 2020 | 435 | 0.030 |
Why?
| | Occupational Exposure | 1 | 2020 | 346 | 0.030 |
Why?
| | Hormone Antagonists | 1 | 2016 | 34 | 0.030 |
Why?
| | Social Support | 1 | 2020 | 629 | 0.030 |
Why?
| | Societies, Medical | 1 | 2020 | 854 | 0.030 |
Why?
| | Algorithms | 1 | 2023 | 1764 | 0.030 |
Why?
| | Prejudice | 1 | 2016 | 60 | 0.030 |
Why?
| | Gonadal Dysgenesis, 46,XY | 1 | 2015 | 1 | 0.030 |
Why?
| | 46, XX Disorders of Sex Development | 1 | 2015 | 7 | 0.030 |
Why?
| | Karyotyping | 1 | 2015 | 104 | 0.030 |
Why?
| | Diabetes Insipidus | 1 | 2015 | 6 | 0.030 |
Why?
| | Holoprosencephaly | 1 | 2015 | 8 | 0.030 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 375 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2020 | 371 | 0.030 |
Why?
| | Thyrotropin | 1 | 2015 | 117 | 0.030 |
Why?
| | Human Growth Hormone | 1 | 2015 | 46 | 0.030 |
Why?
| | Hypogonadism | 1 | 2015 | 92 | 0.030 |
Why?
| | Terminology as Topic | 1 | 2016 | 244 | 0.030 |
Why?
| | Sleep | 1 | 2021 | 879 | 0.030 |
Why?
| | Curriculum | 1 | 2021 | 1030 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2021 | 2132 | 0.030 |
Why?
| | WT1 Proteins | 1 | 2012 | 13 | 0.020 |
Why?
| | SOX9 Transcription Factor | 1 | 2012 | 26 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2800 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2018 | 11194 | 0.020 |
Why?
| | RNA Splicing Factors | 1 | 2012 | 57 | 0.020 |
Why?
| | Genetic Testing | 1 | 2015 | 464 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1658 | 0.020 |
Why?
| | Physicians | 1 | 2020 | 929 | 0.020 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2015 | 545 | 0.020 |
Why?
| | Depression | 1 | 2020 | 1489 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2905 | 0.020 |
Why?
| | Breast Neoplasms | 1 | 2021 | 2247 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3515 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 7039 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2012 | 875 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2855 | 0.020 |
Why?
| | Mass Screening | 1 | 2015 | 1304 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 1483 | 0.010 |
Why?
| | Transcription Factors | 1 | 2012 | 1707 | 0.010 |
Why?
| | Mice | 1 | 2021 | 18092 | 0.010 |
Why?
|
|
Nokoff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|